Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2002
04/02/2002US6365416 Method of preparing delta-9-tetrahydrocannabinol
04/02/2002US6365414 Vitro system for determining formation of Aβ amyloid
04/02/2002US6365413 Includes a heatable rod with a helical guide or channel, a supply of oxidant, and a thin film forming unit; for oil testing
04/02/2002US6365402 Growth differentiation factor-9
04/02/2002US6365393 Recombinant virus with an insertion in the hind iii fragment i region; immunomodulators
04/02/2002US6365392 Amino acid sequences; anthelmintics; nematocides; vaccines; for veterinary medicine
04/02/2002US6365391 Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof
04/02/2002US6365389 Human protein kinase H2LAU20
04/02/2002US6365378 Amplifying a dna fragment, drying product to make powder, supplying powder into solution supply apparatus, adding buffer solution to prepare sample solution; then sample solution is applied directly to chip; reduces loss
04/02/2002US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents
04/02/2002US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others
04/02/2002US6365368 Rapid method for the detection and quantification of microbes in water
04/02/2002US6365366 Mixing active kinase and substrate of defined amino acid sequence, incubating mixture, and detecting phosphorylation rate as indication of kinase activity
04/02/2002US6365363 Bringing open-ended vessel and enzyme solution of cholesterol oxidase, sodium dezoxycholate, and 3-(dodecyldimethylammonio) propanesulfonate buffered to ph 6.8 in contact with skin, then measuring amount of hydrogen peroxide formed
04/02/2002US6365362 Diagnosing early stage cancer by mixing blood sample with colloidal magnetic particles coupled to ligand binding to cancer cells, subjecting mixture to high gradient magnetic field to concentrate bound cancer cells, analyzing for cancer
04/02/2002US6365361 Method for identifying or screening agonist and antagonist to PPAR
04/02/2002US6365360 Methods of identifying modulators of human IP prostaglandin receptor
04/02/2002US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein
04/02/2002US6365357 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
04/02/2002US6365356 Receptors that regulate cell signaling relating to chemokines
04/02/2002US6365351 Non-invasive method for detecting target RNA
04/02/2002US6365344 Screening library of randomized nucleic acids using retroviral vectors to transfect mammalian cells, expressing as extracellular bioactive peptides, contacting other mammalian cells, and screening for changed physiology
04/02/2002US6365341 Stabilization of highly sensitive nucleic acid stains in aqueous solutions
04/02/2002US6365340 Detection of prostatitis
04/02/2002US6365339 Sampling allantoic fluid from embryo, analyzing for peak of sex-specific compound using ion mobility spectrometry, correlating peak with male or female; accurate, efficient and automatable process
04/02/2002US6365337 Genes encoding neuronal voltage-gated calcium channel gamma subunits
04/02/2002US6365159 Spo-rel
04/02/2002US6365155 Monoclonal antibody, antibody fragment, mixture or derivative thereof, which binds to ancrod and inhibits its activity
04/02/2002US6365129 Concurrent analyzing different compounds
04/02/2002US6365127 Isolation of a gene encoding human thyrotropin beta subunit
04/02/2002US6365124 Peptide
04/02/2002US6365109 Reagentless analysis of biological samples
04/02/2002US6365108 Protecting oxygen detector
04/02/2002US6365106 Guide hole; liquid supplying nozzle
04/02/2002US6365035 Method for measuring properties of the stack and the corrosion of materials in a soda recovery unit
04/02/2002US6363803 Vehicle mounted soil sampler
04/02/2002US6363779 Pressure sensor for an internal combustion engine having an intake tube
04/02/2002US6363770 Apparatus for measuring the contents of foreign matters in a flowing liquid
04/02/2002CA2269432C Ho-1 as a diagnostic and prognostic test for dementing diseases
04/02/2002CA2224970C Method of detecting solid cancer cells and tissue atypia and method of testing tissues for use in bone marrow transplantation and peripheral blood stem cell transplantation
04/02/2002CA2147875C Crf binding protein
04/02/2002CA2147639C Method and apparatus for analytical determination of glucose in a biological matrix
04/02/2002CA2140794C Assay for the determination of protein in a biological sample
04/02/2002CA2118197C Measurement of cross-linking by products in crosslinked polyethylene
04/02/2002CA2040267C Diagnostic test slide
04/02/2002CA2006533C Method for the determination of the plasminogen activator activity in samples containing alpha-2-antiplasmin
04/02/2002CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody
03/2002
03/29/2002CA2340303A1 Rna-binding protein
03/28/2002WO2002025630A2 Microfabricated ultrasound array for use as resonant sensors
03/28/2002WO2002025316A2 Acoustically monitoring concrete vessels and structures
03/28/2002WO2002025288A2 Highly sensitive proteomic analysis methods and kits and systems for practicing the same
03/28/2002WO2002025287A2 Detection of peptides
03/28/2002WO2002025286A2 Methods for the diagnosis of neoplastic disorders using angiogenin
03/28/2002WO2002025285A1 Prognostic indicator
03/28/2002WO2002025284A2 High-throughput assays for the proteolytic activities of clostridial neurotoxins
03/28/2002WO2002025283A1 Measuring instrument for immunochromatography
03/28/2002WO2002025282A2 Method for adhesion of polymers to metal-coated substrates
03/28/2002WO2002025281A2 Method for validating biochemically coded security documents and documents of value
03/28/2002WO2002025280A1 Method for monitoring resting and activated platelets in unfixed blood samples
03/28/2002WO2002025278A2 Method for determining the peptide hormone activities or the steroid hormone activities of a material or substance mixture
03/28/2002WO2002025277A1 Heart-lung machine provided with a device for electrical impedance measurement, and method therefore
03/28/2002WO2002025275A2 Micro-invasive method for painless detection of analytes in extracellular space
03/28/2002WO2002025272A1 Method of evaluating the degree of maturity of corneous cells
03/28/2002WO2002025271A2 A method for quantifying the texture homogeneity of a polycrystalline material
03/28/2002WO2002025270A1 Screening systems and methods for identifying modulators of xenobiotic metabolism
03/28/2002WO2002025269A2 Integrated optical flow cytometer with wave guide excitation
03/28/2002WO2002025267A2 Method and apparatus for rapid determination of polymer molecular weight
03/28/2002WO2002025261A1 Diamond electrode for measuring glucose concentration, and measuring method and apparatus employing the same
03/28/2002WO2002025257A1 Quantitative measuring method and apparatus of metal phase using x-ray diffraction method, and method for making plated steel sheet using them
03/28/2002WO2002025256A1 Method to determine the corrosion protection in engine coolants
03/28/2002WO2002025250A2 Isotopic gas analyzer and method of judging absorption capacity of carbon dioxide absorbent
03/28/2002WO2002025246A1 Scanning type probe microscope probe and method of producing the same, and a scanning type probe microscope having this probe and polymer processing method using the same
03/28/2002WO2002024961A1 In vitro assay for measuring the immunogenicity of a vaccine
03/28/2002WO2002024959A2 Multiple reporter read-out for bioassays
03/28/2002WO2002024957A1 Methods and compositions for modulating angiogenesis
03/28/2002WO2002024952A1 Profile array substrates
03/28/2002WO2002024947A2 Cancer associated protein kinases and their uses
03/28/2002WO2002024946A2 Quadruplex dna and duplex probe systems
03/28/2002WO2002024943A2 Method of identifying osteoregenerative agents using differential gene expression
03/28/2002WO2002024942A2 Adp-glucose receptor
03/28/2002WO2002024940A2 Means for the identification of compounds capable of inhibiting karap-transduced signals
03/28/2002WO2002024927A2 Regulation of human adam-ts 1 precursor-like protein
03/28/2002WO2002024924A2 Protein phosphatases
03/28/2002WO2002024920A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/28/2002WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
03/28/2002WO2002024910A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/28/2002WO2002024909A2 Receptor nucleic acids and polypeptides
03/28/2002WO2002024907A2 G-protein coupled receptor hfrbn63
03/28/2002WO2002024896A2 Screening assays for agonists or antagonists of receptor activat or of nf-kb
03/28/2002WO2002024893A2 CHARACTERIZATION OF THE GSK-3β PROTEIN AND METHODS OF USE THEREOF
03/28/2002WO2002024892A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
03/28/2002WO2002024871A1 Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies
03/28/2002WO2002024868A2 Non-human model of gestational and adult folate deficiency and uses thereof
03/28/2002WO2002024815A1 Cyanine dyes
03/28/2002WO2002024749A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/28/2002WO2002024748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/28/2002WO2002024747A2 Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications
03/28/2002WO2002024738A1 β-CATENIN NUCLEAR LOCALIZED PROTEIN
03/28/2002WO2002024733A2 Human polynucleotides and polypeptides encoded thereby
03/28/2002WO2002024726A2 Olfactory and pheromones g-protein coupled receptors